RGEN

Repligen Corporation (RGEN)

About Repligen Corporation (RGEN)

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Details

Daily high

$144.55

Daily low

$141.28

Price at open

$142.67

52 Week High

$198.00

52 Week Low

$113.50

Market cap

7.8B

Dividend yield

0.00%

Volume

17,718

Avg. volume

717,967

P/E ratio

-306.86

Repligen Corporation News